[Federal Register: December 29, 2006 (Volume 71, Number 250)]
[Notices]
[Page 78503-78506]
[DOCID:fr29de06-125]

-----------------------------------------------------------------------

SECURITIES AND EXCHANGE COMMISSION

[Release No. 34-55002; File No. SR-NYSEArca-2006-32]

Self-Regulatory Organizations; NYSE Arca, Inc.; Notice of Filing
and Order Granting Accelerated Approval of Proposed Rule Change to
Trade Various iShares[reg] MSCI Index Funds Pursuant to Unlisted
Trading Privileges

December 21, 2006.
    Pursuant to Section 19(b)(1) of the Securities Exchange Act of 1934
(``Act'') \1\ and Rule 19b-4 thereunder,\2\ notice is hereby given that
on October 18, 2006, NYSE Arca, Inc. (``NYSE Arca'' or ``Exchange'')
filed with the Securities and Exchange Commission (``Commission'') the
proposed rule change as described in Items I and II below, which Items
have been substantially prepared by the Exchange. The Commission is
publishing this notice and order to solicit comments on the proposed
rule change from interested persons and to approve the proposed rule
change on an accelerated basis.
---------------------------------------------------------------------------

    \1\ 15 U.S.C. 78s(b)(1).
    \2\ 17 CFR 240.19b-4.
---------------------------------------------------------------------------

I. Self-Regulatory Organization's Statement of the Terms of Substance
of the Proposed Rule Change

    The Exchange, through its wholly owned subsidiary NYSE Arca
Equities, Inc. (``NYSE Arca Equities''), proposes to trade shares
(``Shares'') of the following Index Funds (``Funds'') pursuant to
unlisted trading privileges (``UTP'') based on NYSE Arca Rule
5.2(j)(3):
     iShares MSCI Brazil (Symbol: EWZ)
     iShares MSCI South Africa (EZA)
     iShares MSCI South Korea (EWY)
     iShares MSCI Taiwan (EWT)
    The text of the proposed rule change is available on the Exchange's
Web site (http://www.nysearca.com), at the principal office of the

Exchange, and at the Commission's Public Reference Room.

II. Self-Regulatory Organization's Statement of the Purpose of, and
Statutory Basis for, the Proposed Rule Change

    In its filing with the Commission, the Exchange included statements
concerning the purpose of, and basis for, the proposed rule change and
discussed any comments it received on the proposed rule change. The
text of these statements may be examined at the places specified in
Item III below. The Exchange has prepared summaries, set forth in
Sections A, B, and C below, of the most significant aspects of such
statements.

A. Self-Regulatory Organization's Statement of the Purpose of, and
Statutory Basis for, the Proposed Rule Change

1. Purpose
    The Exchange is proposing to trade the Shares of the Funds pursuant
to UTP. Each Fund seeks investment results that correspond generally to
the price and yield performance, before fees and expenses, of the
applicable underlying index (``Index''). Each Index is calculated by
Morgan Stanley Capital Investment (``MSCI'') for each trading day based
on official closing prices of the Index components in the applicable
foreign markets. Each Index consists of stocks traded primarily on the
respective country's stock exchange. Each Fund utilizes a passive or
indexing investment approach, which attempts to approximate the
investment performance of its benchmark index through quantitative
analytical

procedures. MSCI generally seeks to have 60% of the capitalization of a
country's stock market reflected in the MSCI Index for such country.
    The Commission previously approved the original listing and trading
of the Shares of the Funds on the American Stock Exchange, LLC.
(``Amex'').\3\ The Funds, with the exception of iShares MSCI South
Africa, were subsequently listed on The New York Stock Exchange
(``NYSE'').\4\ The Exchange deems the Shares to be equity securities,
thus rendering trading in the Shares subject to the Exchange's existing
rules governing the trading of equity securities. Trading hours on the
Exchange for the Shares are the same as those set forth in NYSE Arca
Equities Rule 7.34, except that the Shares issued by MSCI Brazil and
iShares MSCI South Africa will not trade in the Opening Session (4 a.m.
to 9:30 a.m. Eastern Time) unless the Indicative Optimized Portfolio
Value (``IOPV'') is calculated and disseminated during that time. The
iShares MSCI South Korea Index Fund and iShares MSCI Taiwan Index Fund
will trade during the Opening Session, and there is no overlap in
trading hours of the Opening Session and the foreign markets trading
the MSCI South Korea Index and MSCI Taiwan Index securities. The last
calculated IOPV is available to investors during the Opening Session by
means of the consolidated tape or major market data vendors. The IOPV
for these two Funds is unchanged during the Opening Session from its
last calculated value.
---------------------------------------------------------------------------

    \3\ See Securities Exchange Act Release No. 42748 (May 2, 2000),
65 FR 30155 (May 10, 2000) (SR-AMEX-98-49). The Funds were formerly
known as World Equity Benchmark Shares or WEBS.
    \4\ See Securities Exchange Act Release No. 52761 (November 10,
2005), 70 FR 70010 (November 18, 2005) (SR-NYSE-2005-76).
---------------------------------------------------------------------------

    Quotations for and last sale information regarding the Funds are
disseminated through the Consolidated Quotation System. The Index on
which each Fund is based is calculated by MSCI for each trading day in
the applicable foreign market based on official closing prices of the
Index components in such markets. The Indexes are reported periodically
in major financial publications, and the intra-day value of each Index
is disseminated every 15 seconds throughout the trading day by
organizations authorized by MSCI. The net asset value (``NAV'') of each
Fund is calculated and disseminated each business day, normally at the
close of regular trading of the NYSE.
    To provide updated information relating to each Fund for use by
investors, professionals, and persons wishing to create or redeem the
proposed Funds, the IOPV for each Fund as calculated by Bloomberg, L.P.
is disseminated through the facilities of the Consolidated Tape
Association. The IOPV is disseminated on a per-share basis every 15
seconds during regular NYSE trading hours of 9:30 a.m. to 4:15 p.m.
Eastern Time, or, for iShares MSCI South Africa (listed on Amex), 9:30
a.m. to 4 p.m. or 4:15 p.m., depending on the time Amex specifies for
the trading of such Fund's Shares.
    The IOPV may not reflect the value of all securities included in
the applicable Index. In addition, the IOPV does not necessarily
reflect the precise composition of the current portfolio of securities
held by each Fund at a particular point in time. Therefore, the IOPV on
a per-share basis disseminated during NYSE's or Amex's regular trading
hours should not be viewed as a real-time update of the NAV of a
particular Fund, which is calculated only once a day. The IOPV is
intended to closely approximate the value per share of the portfolio of
securities for the Fund and provide for a close proxy of the NAV at a
greater frequency for investors.
    For the iShares MSCI South Korea Index and MSCI Taiwan Index Funds,
there is no overlap in trading hours between the foreign markets and
NYSE. Therefore, for these Funds, the IOPV is calculated based on
closing prices in the principal foreign market for securities in each
Fund's portfolio, which are then converted from the applicable foreign
currency to U.S. dollars. This IOPV is updated every 15 seconds during
NYSE regular trading hours of 9:30 a.m. to 4:15 p.m. E.T. to reflect
changes in currency exchange rates between the U.S. dollar and the
applicable foreign currency.
    The iShares MSCI Brazil and South Africa Index Funds include
companies trading in markets with trading hours overlapping regular
NYSE or Amex trading hours. For each of these Funds, the IOPV
calculator updates the IOPV during the overlap period every 15 seconds
to reflect price changes in the principal foreign market and converts
such prices into U.S. dollars based on the current currency exchange
rate. When the foreign market or markets are closed but NYSE or Amex is
open for trading, the IOPV is updated every 15 seconds to reflect
changes in currency exchange rates.
    The Commission has granted each Fund an exemption from certain
prospectus delivery requirements under Section 24(d) of the Investment
Company Act of 1940 (``1940 Act'').\5\ Any product description used in
reliance on the Section 24(d) exemptive order will comply with all
representations made and all conditions contained in the Funds'
application for orders under the 1940 Act.\6\
---------------------------------------------------------------------------

    \5\ 15 U.S.C. 80a-24(d).
    \6\ See In the Matter of iShares, Inc., et al., Investment
Company Act Release No. 25623 (June 25, 2002).
---------------------------------------------------------------------------

    In connection with the trading of each Fund, the Exchange would
inform ETP Holders in an Information Circular of the special
characteristics and risks associated with trading Shares of such Fund,
including how the Fund Shares are created and redeemed, the prospectus
or product description delivery requirements applicable to the Fund,
applicable Exchange rules, how information about the value of the
underlying index is disseminated, and trading information. The
Information Circular will disclose that the NAV is determined for
Brazil, South Korea, or Taiwan at different times than other MSCI Index
Series. Further, the Information Circular will disclose the possible
market impact of the Fund buying or selling securities in Brazil, South
Korea, or Taiwan prior to the calculation of the NAV.
    In addition, before an ETP Holder recommends a transaction in the
Shares, the ETP Holder must determine the Shares are suitable for the
customer, as required by NYSE Arca Equities Rule 9.2(a)-(b).
    The Exchange intends to utilize its existing surveillance
procedures applicable to derivative products to monitor trading in the
Shares. The Exchange represents that these procedures are adequate to
monitor Exchange trading of the Shares.
2. Statutory Basis
    The Exchange believes that the proposed rule change is consistent
with Section 6(b) of the Act \7\ in general and Section 6(b)(5) of the
Act \8\ in particular in that it is designed to promote just and
equitable principles of trade, to foster cooperation and coordination
with persons engaged in facilitating transactions in securities, to
remove impediments and perfect the mechanisms of a free and open
market, and to protect investors and the public interest. In addition,
the Exchange believes that the proposal is consistent with Rule 12f-5
under the Act \9\ because it deems the Shares to be equity securities,
thus rendering trading in the Shares subject to the Exchange's

existing rules governing the trading of equity securities.
---------------------------------------------------------------------------

    \7\ 15 U.S.C. 78s(b).
    \87\ 15 U.S.C. 78s(b)(5).
    \9\ 17 CFR 240.12f-5.
---------------------------------------------------------------------------

B. Self-Regulatory Organization's Statement on Burden on Competition

    The Exchange does not believe that the proposed rule change would
impose any burden on competition that is not necessary or appropriate
in furtherance of the purposes of the Act.

C. Self-Regulatory Organization's Statement on Comments on the Proposed
Rule Change Received From Members, Participants or Others

    Written comments on the proposed rule change were neither solicited
nor received.

III. Solicitation of Comments

    Interested persons are invited to submit written data, views, and
arguments concerning the foregoing, including whether the proposed rule
change is consistent with the Act. Comments may be submitted by any of
the following methods:

Electronic Comments

     Use the Commission's Internet comment form (http://www.sec.gov/rules/sro.shtml.
); or     Send an e-mail to<EMAIL_ADDRESS>Please include

File Number SR-NYSEArca-2006-32 on the subject line.

Paper Comments

     Send paper comments in triplicate to Nancy M. Morris,
Secretary, Securities and Exchange Commission, 100 F Street, NE.,
Washington, DC 20549-1090.
    All submissions should refer to File Number SR-NYSEArca-2006-32.
This file number should be included on the subject line if e-mail is
used. To help the Commission process and review your comments more
efficiently, please use only one method. The Commission will post all
comments on the Commission's Internet Web site (http://www.sec.gov/rules/sro.shtml
). Copies of the submission, all subsequent amendments,

all written statements with respect to the proposed rule change that
are filed with the Commission, and all written communications relating
to the proposed rule change between the Commission and any person,
other than those that may be withheld from the public in accordance
with the provisions of 5 U.S.C. 552, will be available for inspection
and copying in the Commission's Public Reference Room. Copies of such
filing also will be available for inspection and copying at the
principal office of the Exchange. All comments received will be posted
without change; the Commission does not edit personal identifying
information from submissions. You should submit only information that
you wish to make available publicly. All submissions should refer to
File Number SR-NYSEArca-2006-32 and should be submitted on or before
January 19, 2007.

IV. Commission's Findings and Order Granting Accelerated Approval of
the Proposed Rule Change

    After careful review, the Commission finds that the proposed rule
change is consistent with the requirements of the Act and the rules and
regulations thereunder applicable to a national securities
exchange.\10\ In particular, the Commission finds that the proposed
rule change is consistent with Section 6(b)(5) of the Act,\11\ which
requires that an exchange have rules designed, among other things, to
promote just and equitable principles of trade, to remove impediments
to and perfect the mechanism of a free and open market and a national
market system, and in general to protect investors and the public
interest. The Commission believes that this proposal should benefit
investors by increasing competition among markets that trade the
Shares.
---------------------------------------------------------------------------

    \10\ In approving this rule change, the Commission notes that it
has considered the proposed rule's impact on efficiency,
competition, and capital formation. See 15 U.S.C. 78c(f).
    \11\ 15 U.S.C. 78f(b)(5).
---------------------------------------------------------------------------

    In addition, the Commission finds that the proposal is consistent
with Section 12(f) of the Act,\12\ which permits an exchange to trade,
pursuant to UTP, a security that is listed and registered on another
exchange.\13\ The Commission notes that it previously approved the
listing and trading of the Shares on Amex and, with the exception of
iShares MSCI South Africa, subsequently NYSE.\14\ The Commission also
finds that the proposal is consistent with Rule 12f-5 under the
Act,\15\ which provides that an exchange shall not extend UTP to a
security unless the exchange has in effect a rule or rules providing
for transactions in the class or type of security to which the exchange
extends UTP. The Exchange has represented that it meets this
requirement because it deems the Shares to be equity securities, thus
rendering trading in the Shares subject to the Exchange's existing
rules governing the trading of equity securities.
---------------------------------------------------------------------------

    \12\ 15 U.S.C. 78l(f).
    \13\ Section 12(a) of the Act, 15 U.S.C. 78l(a), generally
prohibits a broker-dealer from trading a security on a national
securities exchange unless the security is registered on that
exchange pursuant to Section 12 of the Act. Section 12(f) of the Act
excludes from this restriction trading in any security to which an
exchange ``extends UTP.'' When an exchange extends UTP to a
security, it allows its members to trade the security as if it were
listed and registered on the exchange even though it is not so
listed and registered.
    \14\ See supra notes 3 and 4.
    \15\ 17 CFR 240.12f-5.
---------------------------------------------------------------------------

    The Commission further believes that the proposal is consistent
with Section 11A(a)(1)(C)(iii) of the Act,\16\ which sets forth
Congress' finding that it is in the public interest and appropriate for
the protection of investors and the maintenance of fair and orderly
markets to assure the availability to brokers, dealers, and investors
of information with respect to quotations for and transactions in
securities. Quotations for and last sale information regarding the
Shares are disseminated through the Consolidated Quotation System.
Furthermore, MSCI updates the applicable IOPV every 15 seconds to
reflect price changes of the Index components in the principal foreign
markets, and converts such prices into U.S. dollars based on the
current currency exchange rate. When the foreign market or markets are
closed but Amex or NYSE is open for trading, the IOPV will be updated
every 15 seconds to reflect changes in currency exchange rates. NYSE
Arca Rule 7.34 describes the situations when the Exchange would halt
trading when the IOPV or the value of the Index underlying one of the
Funds is not calculated or widely available.
---------------------------------------------------------------------------

    \16\ 15 U.S.C. 78k-1(a)(1)(C)(iii).
---------------------------------------------------------------------------

    The Commission notes that, if the Shares of any of the Funds should
be delisted by the listing exchange, the Exchange would no longer have
authority to trade the Shares pursuant to this order.
    In support of this proposal, the Exchange has made the following
representations:
    1. The Exchange's surveillance procedures are adequate to monitor
the trading of the Shares.
    2. In connection with the trading of the Shares, the Exchange would
inform ETP Holders in an Information Circular of the special
characteristics and risks associated with trading the Shares.
    3. The Information Circular would inform participants of the
prospectus or product delivery requirements applicable to the Shares.
    This approval order is conditioned on the Exchange's adherence to
these representations.
    The Commission finds good cause for approving this proposal before
the thirtieth day after the publication of

notice thereof in the Federal Register. As noted previously, the
Commission previously found that the listing and trading of the iShares
MSCI South Africa on Amex and the others Shares on NYSE is consistent
with the Act. The Commission presently is not aware of any regulatory
issue that should cause it to revisit these earlier findings or would
preclude the trading of the Shares on the Exchange pursuant to UTP.
Therefore, accelerating approval of this proposal should benefit
investors by creating, without undue delay, additional competition in
the market for the Shares.

V. Conclusion

    It is therefore ordered, pursuant to Section 19(b)(2) of the
Act,\17\ that the proposed rule change (SR-NYSEArca-2006-32) is
approved on an accelerated basis.
---------------------------------------------------------------------------

    \17\ 15 U.S.C. 78s(b)(2).

    For the Commission, by the Division of Market Regulation,
pursuant to delegated authority.\18\
---------------------------------------------------------------------------

    \18\ 17 CFR 200.30-3(a)(12).
---------------------------------------------------------------------------

Jill M. Peterson,
Assistant Secretary.
[FR Doc. E6-22402 Filed 12-28-06; 8:45 am]

BILLING CODE 8011-01-P


[Federal Register Volume 83, Number 64 (Tuesday, April 3, 2018)]
[Notices]
[Pages 14309-14310]
[FR Doc No: 2018-06747]

-----------------------------------------------------------------------

DEPARTMENT OF TRANSPORTATION

Federal Aviation Administration

Agency Information Collection Activities: Requests for Comments;
Clearance of Revised Approval of Information Collection: Aviation
Maintenance Technician School

AGENCY: Federal Aviation Administration (FAA), DOT.

ACTION: Notice and request for comments.

-----------------------------------------------------------------------

SUMMARY: In accordance with the Paperwork Reduction Act of 1995, FAA
invites public comments about our intention to request the Office of
Management and Budget (OMB) approval to revise an information
collection. The respondents to this information collection are
certificate holders or applicants. The information collected determines
compliance with applicant eligibility and ensures that certificated
AMTSs meet the minimum requirements for procedures and curriculum set
forth by the FAA. This revised filing accounts for the recent
implementation of operation specifications, corrects the current
enrollment figure cited in 2016, and adds sections that were not
previously included in the burden assessment.

DATES: Written comments should be submitted by June 4, 2018.

ADDRESSES: Send comments to the FAA at the following address: Barbara
Hall, Federal Aviation Administration, ASP-110, 10101 Hillwood Parkway,
Fort Worth, TX 76177.
    Public Comments Invited: You are asked to comment on any aspect of
this information collection, including (a) Whether the proposed
collection of information is necessary for FAA's performance; (b) the
accuracy of the estimated burden; (c) ways for FAA to enhance the
quality, utility and clarity of the information collection; and (d)
ways that the burden could be minimized without reducing the quality of
the collected information. The agency will summarize and/or include
your comments in the request for OMB's clearance of this information
collection.

FOR FURTHER INFORMATION CONTACT: Barbara Hall by email at:
[email protected]; phone:<PHONE_NUMBER>

SUPPLEMENTARY INFORMATION:
    OMB Control Number: 2120-0040.
    Title: Aviation Maintenance Technician Schools.
    Form Numbers: FAA Form 8310-6 Aviation Maintenance Technician
School Certificate and Ratings Application.
    Type of Review: This is a revision and correction of the
information collection approved on September 30, 2016, supporting
statement for part 147.
    Background: The FAA program office for part 147, the General
Aviation Branch of Flight Standards, Aircraft Maintenance Division
recognizes there were some discrepancies in the 2016 filing. This
revised information collection corrects the September 30, 2016,
supporting statement approved for part 147. The information collection
burden hours and costs will be noticeably higher than posted in the
2016 supporting statement for three primary reasons:
     First, due to program changes implemented by FAA Notice N
8900.278, dated November 21, 2014, operations specifications (OpSpecs)
were introduced to Title 14 of the Code of Federal Regulations (14 CFR)
part 147 AMTSs. OpSpecs must be issued to institutions with part 147
certificates by July 21, 2015. This correction includes the burden
added by OpSpecs not addressed in the 2016 information collection.
     Second, the current enrollment figures cited in 2016 were
12,500 students but are now 17,800 students.
     Third, some sections of part 147 were not represented as
collecting information and to correct the record, the FAA is including
them in this revised report.
    The respondents to this information collection are part 147
certificate holders or applicants. Currently, there are 177 FAA
certificated AMTSs. The information collected determines compliance
with applicant eligibility and ensures that certificated AMTSs meet the
minimum requirements of part 147. The information collected is focused
on an AMTS' initial curriculum, instructor's qualifications,
maintenance of curriculum, facilities, instructional equipment, and
change of location, if applicable. Recordkeeping requirements address
student attendance, tests, grades, any instruction credited under
section 147.31(c), and authenticated transcripts of student's grades
when credit was given based on training from a previous school. An AMTS
must also keep a current progress chart for each student showing
practical projects completed or to be completed in each subject.
    Respondents: Part 147 AMTS Certificate applicants and Certificate
holders.
    Frequency: Initial certification, on occasion if changes made by
AMTS, and ongoing recordkeeping.

    Estimated Average Burden per Response and Estimated Total Annual
Burden:

                                Table I--Summary Table of Estimated Annual Burden
                                           [177 AMTS, 17,800 students]
----------------------------------------------------------------------------------------------------------------
                                                                  Director @$56/    Instructor    Administrative
              Sec.   147                          Basis                hour          @$28/hour       @$23/hour
----------------------------------------------------------------------------------------------------------------
Sec.   147.5..........................  Initial Certification...             725               0              40
Sec.   147.5..........................  Post Certification......              93               0               8
Sec.   147.21.........................  Initial Certification...            1200             900             300
Sec.   147.23.........................  Initial Certification...              20               0              10
Sec.   147.23.........................  Post Certification......              90               0              45
Sec.   147.33(a)......................  Post Certification......               0           35600           17800
Sec.   147.33(b)......................  Post Certification......               0           17800            8900
Sec.   147.37.........................  Post Certification......              10              10               2
Sec.   147.38.........................  Post Certification......             672             168              84
Sec.   147.41.........................  Post Certification......              32               0               0
----------------------------------------------------------------------------------------------------------------
    Total annual estimated part 147     Initial Cert hours......            1945             900             350
     burden.
                                        Post Cert hours.........             897           53578           26839
                                                                 -----------------------------------------------
                                        Total hours burden......            2842           54478           27189
----------------------------------------------------------------------------------------------------------------

    Issued in Fort Worth, TX, on March 21, 2018.
Barbara L. Hall,
FAA Information Collection Clearance Officer, Performance, Policy, and
Records Management Branch, ASP-110.
[FR Doc. 2018-06747 Filed 4-2-18; 8:45 am]
BILLING CODE 4910-13-P


[Federal Register Volume 77, Number 7 (Wednesday, January 11, 2012)]
[Proposed Rules]
[Pages 1656-1657]
[FR Doc No: 2012-284]

-----------------------------------------------------------------------

DEPARTMENT OF TRANSPORTATION

Federal Aviation Administration

14 CFR Part 71

[Docket No. FAA-2011-0117; Airspace Docket No. 09-AGL-31]
RIN 2120-AI92

Proposed Establishment of Restricted Areas R-5402, R-5403A, R-
5403B, R-5403C, R-5403D, R-5403E, R-5403F; Devils Lake, ND

AGENCY: Federal Aviation Administration (FAA), DOT.

ACTION: Notice of proposed rulemaking (NPRM); extension of comment
period.

-----------------------------------------------------------------------

SUMMARY: This action extends the comment period for an NPRM that was
published on November 28, 2011. In that document, the FAA proposed to
establish restricted area airspace within the Devils Lake East Military
Operations Area (MOA), overlying Camp Grafton Range, in the vicinity of
Devils Lake, ND. This extension is a result of a request from the North
Dakota Aviation Council (NDAC), representing eight member groups
including the Airport Association of North Dakota, North Dakota
Business Aviation Association, North Dakota Pilots Association, North
Dakota Professional Aviation Mechanics Association, and North Dakota
Flying Farmers, to extend the comment period to the proposal.

DATES: The comment period for the NPRM published on November 28, 2011
(76 FR 72869), scheduled to close on January 12, 2012, is extended
until February 12, 2012.

ADDRESSES: You may send comments identified by Docket Number FAA-2011-
0017 and Airspace Docket No. 09-AGL-31 using any of the following
methods:
     Federal eRulemaking Portal: Go to http://www.regulations.gov and follow the instructions for sending your
comments electronically.
     Mail: Send comments to U.S. Department of Transportation,
Docket Operations, M-30, West Building Ground Floor, Room W12-140, 1200
New Jersey Avenue SE., Washington, DC 20590.
     Fax: Fax comments to Docket Operations at<PHONE_NUMBER>.
     Hand Delivery: Bring comments to U.S. Department of
Transportation, Docket Operations, M-30, West Building Ground Floor,
Room W12-140, 1200 New Jersey Avenue SE., Washington, DC 20590, between
9 a.m. and 5 p.m., Monday through Friday, except Federal holidays.
    Privacy: We will post all comments we receive, without change, to
http://www.regulations.gov, including any personal information you
provide. Using the search function of our docket Web site, anyone can
find and read the comments received into any of our dockets, including
the name of the individual sending the comment (or signing the comment
for an association, business, labor union, etc.). You may review DOT's
complete Privacy Act Statement in the Federal Register published on
April 11, 2000 (65 FR 19477-78) or you may visit http://DocketsInfo.dot.gov.
    Docket: To read background documents or comments received, go to
http://www.regulations.gov at any time or to Docket Operations in Room
W12-140 of the West Building Ground Floor at 1200 New Jersey Avenue
SE., Washington, DC, between 9 a.m. and 5 p.m., Monday through Friday,
except Federal holidays.

FOR FURTHER INFORMATION CONTACT: Colby Abbott, Airspace, Regulations
and ATC Procedures Group, Office of Airspace Services, Federal Aviation
Administration, 800 Independence Avenue SW., Washington, DC 20591,
telephone<PHONE_NUMBER>.

SUPPLEMENTARY INFORMATION:

Comments Invited

    The FAA invites interested persons to participate in this
rulemaking by submitting written comments, data, or views. We also
invite comments relating to the economic, environmental, energy, or
federalism impacts that might result from adopting the proposals in
this document. The most helpful comments reference a specific portion
of the proposal, explain the reason for any recommended change, and
include supporting data. To ensure the docket does not contain
duplicate comments, please send only one copy of written comments, or
if you are filing comments electronically, please submit your comments
only one time.
    We will file in the docket all comments we receive, as well as a
report summarizing each substantive public contact with FAA personnel
concerning this proposed rulemaking. Before acting on this proposal, we
will consider all comments we receive on or before the closing date for
comments. We will consider comments filed after the comment period has
closed if it is possible to do so without incurring expense or delay.
We may change this proposal in light of the comments we receive.

Background

    On November 28, 2011, the Federal Aviation Administration (FAA)
issued Docket No. FAA-2011-0117; Airspace Docket No. 09-AGL-31,
Proposed Establishment of Restricted Areas R-5402, R-5403A, R-5403B, R-
5403C, R-5403D, R-5403E, R-5403F; Devils Lake, ND (76 FR 72869;
November 28, 2011). Comments to that document were to be received on or
before January 12, 2012.
    By request submitted to the docket on January 2, 2012, the NDAC,
representing eight member groups including the Airport Association of
North Dakota, North Dakota Business Aviation Association, North Dakota
Pilots Association, North Dakota Professional Aviation Mechanics
Association, and North Dakota Flying Farmers, requested that the FAA
extend the comment period for Airspace Docket FAA-2011-0117; Airspace
Docket No. 09-AGL-31 from January 12, 2012, to April 30, 2012. The
organizations requesting an extension stated that the comment period
deadline of January 12, 2011, did not allow adequate time to respond.
They noted that the comment period between the November 28, 2011 notice
and the January 12, 2012 deadline provided very little opportunity to
research the issue, gain comments and adequately consider the issue.
The NDAC offered their eight member organization are holding their
annual meetings during the Upper Midwest Aviation Symposium, scheduled
for March 4-6, 2012, and plan to use the opportunity to discuss the
proposal, gain insight into concerns, and receive position guidance
from their members related to the proposed action; hence the extension
request to April 30, 2012. Additionally, the NDAC commented the
Christmas and New Year holiday season fell within the comment period
which greatly reduced the ability to communicate and get meaningful
coordination completed.
    The FAA supports the petitioners' request for an extension of the
comment period on Docket No. FAA-2011-0117; Airspace Docket No. 09-AGL-
31, for an additional 30 days in lieu of the 120-day extension
requested. The FAA believes a 120-day extension of the existing 45-day
comment period for the proposed action to be excessive and
unreasonable. The FAA must balance the length of the comment period
against the need to proceed expeditiously with airspace actions that
support realistic training requirements in modern tactics for the
military as we manage the safe and efficient use of the National
Airspace System. The FAA believes an additional 30 days would be
adequate for commenters to collect cost and operational data necessary
to provide meaningful comment to Docket No. FAA-2011-0117; Airspace
Docket No. 09-AGL-31. The FAA does not anticipate any further extension
of the comment period for this rulemaking.

Extension of Comment Period

    In accordance with section 11.47(c) of title 14, Code of Federal
Regulations, the FAA has reviewed the request submitted by the North
Dakota Aviation Council for extension of the comment period to Docket
No. FAA-2011-0117; Airspace Docket No. 09-AGL-31. This petitioner has
shown a substantive interest in the proposed rule and good cause for
the extension. The FAA has determined that extension of the comment
period is consistent with the public interest, and that good cause
exists for taking this action.
    Accordingly, pursuant to the authority delegated to me, the comment
period for Docket No. FAA-2011-0117; Airspace Docket No. 09-AGL-31
published in the Federal Register on November 28, 2011 (76 FR 72869),
FR Doc. 2011-30495, is extended until February 12, 2012.

    Issued in Washington, DC, on January 5, 2012.
Gary A. Norek,
Acting Manager, Airspace, Regulations and ATC Procedures Group.
[FR Doc. 2012-284 Filed 1-10-12; 8:45 am]
BILLING CODE 4910-13-P


EPA Registration Division Contact: Sidney Jackson.<PHONE_NUMBER>.

Docket ID: EPA-HQ-OPP-2007-0300

Interregional Research Project No. 4 (IR-4),

PP#: 7E7255

EPA has received pesticide petition (PP 7E7255) from the IR-4 Project
Headquarters, 500 College Road East, Suite 201W, Princeton, New Jersey,
08540, proposing pursuant to section 408 (d) of the Federal Food, Drug
and Cosmetic Act, 21 U.S.C. 346a(d), to amend 40 C. F. R. § 180.418 by
establishing tolerances for residues of the insecticide
zeta-cypermethrin  (S-Cyano(3-phenoxyphenyl)methyl (+() cis-trans
3-(2,2-dichloroethenyl)-2,2 dimethylcyclopropanecarboxylate and its
inactive isomers) in or on the raw agricultural commodities: borage,
seed at 0.2 parts per million (ppm); castor oil plant, seed at 0.2 ppm;
Chinese tallowtree, seed at 0.2 ppm; crambe, seed at 0.2 ppm; cuphea,
seed at 0.2 ppm; echium, seed at 0.2 ppm; euphorbia, seed at 0.2 ppm;
evening primrose, seed at 0.2 ppm; flax, seed at 0.2 ppm; gold of
pleasure, seed at 0.2 ppm; hare’s ear mustard, seed at 0.2 ppm;
jojoba, seed at 0.2 ppm; lesquerella, seed at 0.2 ppm; lunara, seed at
0.2 ppm; meadowfoam, seed at 0.2 ppm; milkweed, seed at 0.2 ppm;
mustard, seed at 0.2 ppm; niger seed, seed at 0.2 ppm; oil radish, seed
at 0.2 ppm; poppy, seed at 0.2 ppm; rose hip, seed at 0.2 ppm; sesame,
seed at 0.2 ppm; stokes aster, seed at 0.2 ppm; sweet rocket, seed at
0.2 ppm; tallowwood, seed at 0.2 ppm; tea oil plant, seed at 0.2 ppm;
and vernonia, seed at 0.2 ppm.  EPA has determined that the petition
contains data or information regarding the elements set forth in section
408(d)(2) of the FFDCA; however, EPA has not fully evaluated the
sufficiency of the submitted data at this time or whether the data
support granting of the petition.  Additional data may be needed before
EPA rules on the petition.

A.  Residue Chemistry

1.  Plant metabolism.  The metabolism of cypermethrin in plants is
adequately understood.  Studies have been conducted to delineate the
metabolism of radiolabelled cypermethrin in various crops all showing
similar results.  The residue of concern is the parent compound only.

2.  Analytical method. There is a practical analytical method for
detecting and measuring

levels of cypermethrin in or on food with a limit of detection that
allows monitoring of food with residues at or above the levels set in
these tolerances (Gas Chromatography with Electron Capture Detection
(GC/ECD).

3.  Magnitude of residues.

Crop field trial residue data from studies conducted at the maximum
label rates for representative commodities for canola (rapeseed),
sunflower, and safflower show that the proposed zeta-cypermethrin
tolerances on borage, seed, 0.2 ppm; castor oil plant, seed, 0.2 ppm;
Chinese tallowtree, seed, 0.2 ppm; crambe, seed, 0.2 ppm; cuphea, seed,
0.2 ppm; echium, seed, 0.2 ppm; euphorbia, seed, 0.2 ppm; evening
primrose, seed, 0.2 ppm; flax, seed, 0.2 ppm; gold of pleasure, seed,
0.2 ppm; hare’s ear mustard, seed, 0.2 ppm; jojoba, seed, 0.2 ppm;
lesquerella, seed, 0.2 ppm; lunara, seed, 0.2 ppm; meadowfoam, seed, 0.2
ppm; milkweed, seed, 0.2 ppm; mustard, seed, 0.2 ppm; niger seed, seed,
0.2 ppm; oil radish, seed, 0.2 ppm; poppy, seed, 0.2 ppm; rose hip,
seed, 0.2 ppm; sesame, seed, 0.2 ppm; stokes aster, seed, 0.2 ppm; sweet
rocket, seed, 0.2 ppm; tallowwood, seed, 0.2 ppm; tea oil plant, seed,
0.2 ppm; and vernonia, seed, 0.2 ppm, will not be exceeded when the
zeta-cypermethrin products labeled for these uses are used as directed.

B.  Toxicological Profile

1.  Acute toxicity.  For the purposes of assessing acute dietary risk,
FMC has used the NOEL of 10.0 mg/kg/day from the zeta-cypermethrin acute
neurotoxicity study in rats.  The LOAEL of  50.0 mg/kg/day was based on
clinical signs. This acute dietary endpoint is used to determine acute
dietary risks to all population subgroups.

2.  Genotoxicity.  The following genotoxicity tests were all negative:
in vivo chromosomal aberration in rat bone marrow cells; in vitro
cytogenic chromosome aberration; unscheduled DNA synthesis; CHO/HGPTT
mutagen assay; weakly mutagenic:  gene mutation (Ames).

3.  Reproductive and developmental toxicity.  No evidence of additional
sensitivity to young rats was observed following pre- or postnatal
exposure to zeta-cypermethrin.

a.  A two-generation reproductive toxicity study with zeta-cypermethrin
in rats demonstrated a NOEL of  7.0 mg/kg/day and a LOEL of  27.0
mg/kg/day for parental/systemic toxicity based on body weight, organ
weight, and clinical signs.  There were no adverse effects in
reproductive performance.  The NOEL for reproductive toxicity was
considered to be  > 45.0 mg/kg/day (the highest dose tested).

b.  A developmental study with zeta-cypermethrin in rats demonstrated a
maternal NOEL of 12.5 mg/kg/day and a LOEL of 25 mg/kg/day based on
decreased maternal body weight gain, food consumption and clinical
signs.  There were no signs of developmental toxicity at 35.0 mg/kg/day,
the highest dose level tested.

c. A developmental study with cypermethrin in rabbits demonstrated a
maternal NOEL of 100 mg/kg/day and a LOEL of 450 mg/kg/day based on
decreased body weight gain.  There were no signs of developmental
toxicity at 700 mg/kg/day, the highest dose level tested.

4.  Subchronic toxicity.  Short- and intermediate-term toxicity
(incidental oral exposure).  The NOEL of 10.0 mg/kg/day based on
clinical signs at the LEL of 50.0 mg/kg/day in the zeta-cypermethrin
acute neurotoxicity study in rats would also be used for short-term
%aPAD and MOE calculations (as well as acute, discussed in (1) above),
and the NOEL of 5.0 mg/kg/day based on decreased motor activity in the
zeta-cypermethrin subchronic neurotoxicity study in rats, would be used
for intermediate-term MOE calculations.

5.  Chronic toxicity.  a. The chronic reference dose (RfD) of 0.06
mg/kg/day for zeta-cypermethrin is based on a NOEL of 6.0 mg/kg/day from
a cypermethrin chronic feeding study in dogs and an uncertainty factor
of 100.  The endpoint effect of concern was based on clinical signs.

b.  Cypermethrin is classified as a Group C chemical (possible human
carcinogen with limited evidence of carcinogenicity in animals) based
upon limited evidence for carcinogenicity in female mice; assignment of
a Q* has not been recommended.

6.  Animal metabolism.  The metabolism of cypermethrin in animals is
adequately understood.  Cypermethrin has been shown to be rapidly
absorbed, distributed, and excreted in rats when administered orally.
Cypermethrin is metabolized by hydrolysis and oxidation.

7.  Metabolite toxicology.  The Agency has previously determined that
the metabolites of cypermethrin are not of toxicological concern and
need not be included in the tolerance expression nor in the risk
exposure assessments.

8.  Endocrine Disruption.  No special studies investigating potential
estrogenic or other endocrine effects of cypermethrin have been
conducted.  However, no evidence of such effects were reported in the
standard battery of required toxicology studies which have been
completed and found acceptable.  Based on these studies, there is no
evidence to suggest that cypermethrin has an adverse effect on the
endocrine system.

C.  Aggregate Exposure

1.  Dietary exposure.  a.  Food.  Permanent tolerances, in support of
registrations, currently exist for residues of zeta-cypermethrin on:
alfalfa hay, alfalfa forage, alfalfa seed, aspirated grain fractions,
sugar beets (roots and tops), head, stem and leafy Brassica vegetables,
cabbage, field corn grain, pop corn grain, field corn forage, field corn
stover, pop corn stover, sweet corn (K+CWHR), sweet corn forage, sweet
corn stover, cottonseed, dried shelled peas and beans, edible podded
legume vegetables, fruiting vegetables (except Cucurbits), leafy
vegetables, head lettuce, bulb and green onions, pecans, rice grain,
rice hulls, rice straw, sorghum forage, sorghum grain, sorghum stover,
soybean seed, succulent shelled peas and beans, sugarcane, wheat forage,
wheat grain, wheat hay, wheat straw, almond hulls, nongrass animal feed
forage and hay, berries, cilantro leaves, pome fruit, stone fruit,
grape, grass forage and hay, tree nuts, peanut, rapeseed (canola),
sunflower, sunflower refined oil, turnip greens, cucurbit vegetables,
root and tuber vegetables, meat, fat and meat byproducts of cattle,
goats, hogs, horses and poultry, eggs, milk and milk fat.  For the
purposes of assessing the potential dietary exposure for these existing
and the subject proposed tolerances, FMC has utilized available
information on anticipated residues, monitoring data and percent crop
treated as follows:

i.  Acute exposure and risk.  Acute dietary exposure risk assessments
are performed for a food-use pesticide if a toxicological study has
indicated the possibility of an effect of concern occurring as a result
of a one day or single exposure.  For the purposes of assessing acute
dietary risk for zeta-cypermethrin, FMC has used the NOEL of 10.0
mg/kg/day from the zeta-cypermethrin acute neurotoxicity study in rats
with an uncertainty factor (UF) of 100 (acute RfD = 0.10 mg/kg/day).
The LEL of 50.0 mg/kg/day was based on clinical signs.  This acute
dietary endpoint is used to determine acute dietary risks to all
population subgroups.  Available information on anticipated residues,
monitoring data and percent crop treated was incorporated into a Tier 3
analysis, using Monte Carlo modeling for commodities that may be
consumed in a single serving.  These assessments show that the percent
acute Population Adjusted Dose (%aPAD) all fall below the EPA’s level
of concern ((100%).   The 95th percentile of exposure for the overall U.
S. population was estimated to be 0.002448 mg/kg/day (%aRfD of 2.45);
99th percentile 0.007176 mg/kg/day (%aRfD of 7.18); and 99.9th
percentile 0.024759 mg/kg/day (%aRfD of 24.76).  The 95th percentile of
exposure for all infants (< 1 year) was estimated to be 0.005153
mg/kg/day (%aRfD of 5.15); 99th percentile 0.012833 mg/kg/day (%aRfD of
12.83); and 99.9th percentile 0.035742 mg/kg/day (%aRfD of 35.74). The
95th percentile of exposure for children 1 to 2 years old and children 3
to 5 years old was estimated to be, respectively,  0.006932 mg/kg/day
(%aRfD of 6.93) and 0.004758 mg/kg/day (%aRfD of 4.76); 99th percentile
0.016035 mg/kg/day (%aRfD of 16.03) and 0.011416 (%aRfD of 11.42); and
99.9th percentile 0.053308 mg/kg/day (%aRfD of 53.31) and 0.047651
(%aRfD of 47.65). The 95th percentile of exposure for females (13-49
years) was estimated to be 0.001983 mg/kg/day (%aRfD of 1.98); 99th
percentile 0.005391 mg/kg/day (%aRfD of 5.39); and 99.9th percentile
0.020292 mg/kg/day (%aRfD of 20.29).  Therefore, FMC concludes that the
acute dietary risk of zeta-cypermethrin, as estimated by the dietary
risk assessment, does not appear to be of concern.

Chronic exposure and risk.  The chronic reference dose (cRfD) of 0.06
mg/kg/day for zeta-cypermethrin is based on a NOEL of 6.0 mg/kg/day from
a cypermethrin chronic feeding study in dogs and an uncertainty factor
of 100.  The endpoint effect of concern was based on clinical signs.  A
chronic dietary exposure/risk assessment has been performed for
zeta-cypermethrin using the above cRfD.  Available information on
anticipated residues, monitoring data and percent crop treated was
incorporated into the analysis to estimate the anticipated residue
contribution (ARC).  The ARC is generally considered a more realistic
estimate than an estimate based on tolerance level residues.  The ARC
are estimated to be 0.000958 mg/kg body weight (bwt)/day and utilize 1.6
percent of the cRfD for the overall U. S. population.  The ARC for all
infants (<1 year) are estimated to be 0.001486 mg/kg bwt/day and
utilizes 2.5 percent of the cRfD.  The ARC for children 1 to 2 years old
and children 3 to 5 years old are estimated to be 0.003881 mg/kg bwt/day
and 0.002680 mg/kg bwt/day and utilizes 6.5 percent and 4.5 percent of
the cRfD, respectively. The ARC for females (13-49 years) is estimated
to be 0.000631 mg/kg bwt/day and utilizes 1.1 percent of the RfD.
Generally speaking, the EPA has no cause for concern if the total
dietary exposure from residues for uses for which there are published
and proposed tolerances is less than 100 percent of the cRfD.
Therefore, FMC concludes that the chronic dietary risk of
zeta-cypermethrin, as estimated by the dietary risk assessment, does not
appear to be of concern.

Drinking water.  Laboratory and field data have demonstrated that
cypermethrin is immobile in soil and will not leach into groundwater.
Other data show that cypermethrin is virtually insoluble in water and
extremely lipophilic.  As a result, FMC concludes that residues reaching
surface waters from field runoff will quickly adsorb to sediment
particles and be partitioned from the water column.  Drinking water
estimated concentrations (DWEC) and the corresponding drinking water
level of comparison (DWLOC) values were calculated for chronic and acute
exposures. The results show that all DWLOC values exceed the DWEC
values. Thus, exposure to zetacypermethrin and cypermethrin residues in
drinking water is not of concern.

US EPA’s draft SOP for Incorporating Estimates of Drinking Water
Exposure Into Aggregate Risk Assessments was used to perform a drinking
water analysis.  This SOP utilizes a variety of tools to conduct
drinking water assessment. These tools include water models such as FQPA
Index Reservoir Screening Tool (FIRST), PRZM/EXAMS, SCIGROW and
monitoring data. If monitoring data are not available then the models
are used to predict potential residues in drinking water. The technique
recommended in the drinking water SOP compares a calculated Drinking
Water Level of Comparison (DWLOC) value to the Drinking Water Estimated
Concentration (DWEC) value. The DWEC value results from either the
monitoring data residues or modeled water residues. If the DWLOC value
exceeds the DWEC value then there is reasonable certainty that no harm
will result from the acute or chronic aggregate exposure.

In the case of cypermethrin and zetacypermethrin, monitoring data do not
exist.  Therefore, the FIRST model was used to estimate a surface water
residue.  The risk assessment for drinking water compares two values:
the DWLOC and the DWEC. The DWLOC is the drinking water level of
comparison. This is the maximum allowable drinking water concentration
(in ppb). The DWEC is the drinking water

environmental concentration, which is derived either from monitoring
studies or from modeling.

If the DWLOC is greater than the DWEC, then the overall exposure from
water, food, and

residential is considered to be acceptable. The calculated DWLOC values
for acute and chronic exposures for all adults, adult females and
children exceed the modeled DWEC surface water residues. Therefore,
there is reasonable certainty that no harm will result from cumulative
and aggregate (food and water) exposure to cypermethrin and
zetacypermethrin residues.

2.  Non-dietary exposure.   Zeta-cypermethrin is registered for
agricultural crop applications only, therefore non-dietary exposure
assessments are not warranted.

D.  Cumulative Effects.  In consideration of potential cumulative
effects of cypermethrin and other substances that may have a common
mechanism of toxicity, to our knowledge there are currently no available
data or other reliable information indicating that any toxic effects
produced by cypermethrin would be cumulative with those of other
chemical compounds; thus only the potential risks of cypermethrin have
been considered in this assessment of its aggregate exposure.  FMC
intends to submit information for the EPA to consider concerning
potential cumulative effects of cypermethrin consistent with the
schedule established by EPA at 62 Federal Register 42020 (August 4,
1997) and other EPA publications pursuant to the Food Quality Protection
Act.

E.  Safety Determination

1.  U. S. population.  The chronic reference dose (cRfD) of 0.06
mg/kg/day for zeta-cypermethrin is based on a NOEL of 6.0 mg/kg/day from
a cypermethrin chronic feeding study in dogs and an uncertainty factor
of 100.  The endpoint effect of concern was based on clinical signs.  A
chronic dietary exposure/risk assessment has been performed for
zeta-cypermethrin using the above cRfD.  Available information on
anticipated residues, monitoring data and percent crop treated was
incorporated into the analysis to estimate the anticipated residue
contribution (ARC).  The ARC is generally considered a more realistic
estimate than an estimate based on tolerance level residues. The ARC are
estimated to be 0.000958 mg/kg body weight (bwt)/day and utilize 1.6
percent of the cRfD for the overall U. S. population.  The ARC for all
infants (<1 year) are estimated to be 0.001486 mg/kg bwt/day and
utilizes 2.5 percent of the cRfD.  The ARC for children 1 to 2 years old
and children 3 to 5 years old are estimated to be 0.003881 mg/kg bwt/day
and 0.002680 mg/kg bwt/day and utilizes 6.5 percent and 4.5 percent of
the cRfD, respectively. The ARC for females (13-49 years) is estimated
to be 0.000631 mg/kg bwt/day and utilizes 1.1 percent of the RfD.
Generally speaking, the EPA has no cause for concern if the total
dietary exposure from residues for uses for which there are published
and proposed tolerances is less than 100 percent of the cRfD.
Therefore, FMC concludes that the chronic dietary risk of
zeta-cypermethrin, as estimated by the dietary risk assessment, does not
appear to be of concern.

Acute dietary exposure risk assessments are performed for a food-use
pesticide if a toxicological study has indicated the possibility of an
effect of concern occurring as a result of a one day or single exposure.
 For the purposes of assessing acute dietary risk for zeta-cypermethrin,
FMC has used the NOEL of 10.0 mg/kg/day from the zeta-cypermethrin acute
neurotoxicity study in rats with an uncertainty factor (UF) of 100
(acute RfD = 0.10 mg/kg/day).  The LEL of 50.0 mg/kg/day was based on
clinical signs.  This acute dietary endpoint is used to determine acute
dietary risks to all population subgroups.  Available information on
anticipated residues, monitoring data and percent crop treated was
incorporated into a Tier 3 analysis, using Monte Carlo modeling for
commodities that may be consumed in a single serving.  These assessments
show that the percent acute Population Adjusted Dose (%aPAD) all fall
below the EPA’s level of concern ((100%).   The 95th percentile of
exposure for the overall U. S. population was estimated to be 0.002448
mg/kg/day (%aRfD of 2.45); 99th percentile 0.007176 mg/kg/day (%aRfD of
7.18); and 99.9th percentile 0.024759 mg/kg/day (%aRfD of 24.76).  The
95th percentile of exposure for all infants (< 1 year) was estimated to
be 0.005153 mg/kg/day (%aRfD of 5.15); 99th percentile 0.012833
mg/kg/day (%aRfD of 12.83); and 99.9th percentile 0.035742 mg/kg/day
(%aRfD of 35.74). The 95th percentile of exposure for children 1 to 2
years old and children 3 to 5 years old was estimated to be,
respectively,  0.006932 mg/kg/day (%aRfD of 6.93) and 0.004758 mg/kg/day
(%aRfD of 4.76); 99th percentile 0.016035 mg/kg/day (%aRfD of 16.03) and
0.011416 (%aRfD of 11.42); and 99.9th percentile 0.053308 mg/kg/day
(%aRfD of 53.31) and 0.047651 (%aRfD of 47.65). The 95th percentile of
exposure for females (13-49 years) was estimated to be 0.001983
mg/kg/day (%aRfD of 1.98); 99th percentile 0.005391 mg/kg/day (%aRfD of
5.39); and 99.9th percentile 0.020292 mg/kg/day (%aRfD of 20.29).
Therefore, FMC concludes that the acute dietary risk of
zeta-cypermethrin, as estimated by the dietary risk assessment, does not
appear to be of concern.

2.  Infants and children.  a.  General.  In assessing the potential for
additional sensitivity of infants and children to residues of
zeta-cypermethrin, FMC considered data from developmental toxicity
studies in the rat and rabbit, and a two-generation reproductive study
in the rat.  The data demonstrated no indication of increased
sensitivity of rats to zeta-cypermethrin or rabbits to cypermethrin in
utero and/or postnatal exposure to zeta-cypermethrin or cypermethrin.
The developmental toxicity studies are designed to evaluate adverse
effects on the developing organism resulting from pesticide exposure
during prenatal development to one or both parents. Reproduction studies
provide information relating to effects from exposure to the pesticide
on the reproductive capability of mating animals and data on systemic
toxicity.  FFDCA section 408 provides that EPA may apply an additional
margin of safety for infants and children in the case of threshold
effects to account for pre- and post-natal toxicity and the completeness
of the database.

b. Developmental toxicity studies.  In the prenatal developmental
toxicity studies in rats and rabbits, there was no evidence of
developmental toxicity at the highest doses tested (35.0 mg/kg/day in
rats and 700 mg/kg/day in rabbits).  Decreased body weight gain was
observed at the maternal LOEL in each study; the maternal NOEL was
established at 12.5 mg/kg/day in rats and 100 mg/kg/day in rabbits.

c.  Reproductive toxicity study. In the two-generation reproduction
study in rats, offspring toxicity (body weight) and parental toxicity
(body weight, organ weight, and clinical signs) was observed at 27.0
mg/kg/day and greater.  The parental systemic NOEL was 7.0 mg/kg/day and
the parental systemic LOEL was 27.0 mg/kg/day.  There were no
developmental (pup) or reproductive effects up to 45.0 mg/kg/day,
highest dose tested.

d.  Pre- and post-natal sensitivity.  i.   Pre-natal. There was no
evidence of developmental toxicity in the studies at the highest doses
tested in the rat (70.0 mg/kg/day) or in the rabbit (700 mg/kg/day).
Therefore, there is no evidence of a special dietary risk (either acute
or chronic) for infants and children which would require an additional
safety factor.

ii.  Post-natal. Post-natal. Based on the absence of pup toxicity up to
dose levels which produced toxicity in the parental animals, there is no
evidence of special post-natal sensitivity to infants and children in
the rat reproduction study.

e.  Conclusion.  Based on the above, FMC concludes that reliable data
support use of the standard 100-fold uncertainty factor, and that an
additional uncertainty factor is not needed to protect the safety of
infants and children.  As stated above, aggregate exposure assessments
utilized significantly less than 1 percent of the RfD for either the
entire U. S. population or any of the 26 population subgroups including
infants and children.  Therefore, it may be concluded that there is
reasonable certainty that no harm will result to infants and children
from aggregate exposure to cypermethrin residues.

F.  International Tolerances.

There are no Canadian, or Mexican residue limits for residues of
cypermethrin or zeta-cypermethrin in or on representative commodities
for oilseed crops.

The Codex MRLs for cypermethrin are oilseed, except peanut at 0.2 ppm.

ZETA.IR4.AUG2007

Page  PAGE  1


[Federal Register Volume 87, Number 213 (Friday, November 4, 2022)]
[Notices]
[Pages 66769-66771]
[FR Doc No: 2022-23981]

=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF TRANSPORTATION

Federal Motor Carrier Safety Administration

[Docket No. FMCSA-2022-0093]

Agency Information Collection Activities; Renewal of an Approved
Information Collection: Commercial Driver's License Drug and Alcohol
Clearinghouse

AGENCY: Federal Motor Carrier Safety Administration (FMCSA), Department
of Transportation (DOT).

ACTION: Notice and request for comments.

-----------------------------------------------------------------------

SUMMARY: In accordance with the Paperwork Reduction Act of 1995, FMCSA
announces its plan to submit the Information Collection Request (ICR)
described below to the Office of Management and Budget for its review
and approval and invites public comment. The FMCSA requests to renew an
ICR titled, ``Commercial Driver's License Drug and Alcohol
Clearinghouse.'' The Agency's final rule, published December 5, 2016,
titled ``Commercial Driver's License Drug and Alcohol Clearinghouse''
(81 FR 87686) (Clearinghouse) established the regulatory requirements
for the Clearinghouse. The compliance date of the final rule was
January 6, 2020. The FMCSA began collecting data as authorized users
began registering in the Clearinghouse in September 2019. This ICR is
needed to ensure that querying and reporting requirements are met to
diminish the problem of commercial driver's license (CDL) and
commercial learner's permit (CLP) holders who test positive for drugs
or alcohol and then continue to perform safety sensitive functions,
including driving a commercial motor vehicle (CMV), without
participating in the required return-to-duty (RTD) process.

DATES: Comments on this notice must be received on or before January 3,
2023

ADDRESSES: You may submit comments identified by Federal Docket
Management System (FDMS) Docket Number FMCSA-2022-0093 using any of the
following methods:
     Federal eRulemaking Portal: https://www.regulations.gov.
Follow the online instructions for submitting comments.
     Fax: 1-202-493-2251.
     Mail: Docket Operations; U.S. Department of
Transportation, 1200 New Jersey Avenue SE, West Building, Ground Floor,
Room W12-140, Washington, DC 20590-0001.
     Hand Delivery or Courier: U.S. Department of
Transportation, 1200 New Jersey Avenue SE, West Building, Ground Floor,
Room W12-140, Washington, DC 20590-0001 between 9 a.m. and 5 p.m. e.t.,
Monday through Friday, except Federal holidays.
    Instructions: All submissions must include the Agency name and
docket number. For detailed instructions on submitting comments, see
the Public Participation heading below. Note that all comments received
will be posted without change to https://www.regulations.gov, including
any personal information provided. Please see the Privacy Act heading
below.
    Docket: For access to the docket to read background documents or
comments received, go to https://www.regulations.gov, and follow the
online instructions for accessing the docket, or go to the street
address listed above.
    Privacy: In accordance with 5 U.S.C. 553(c), DOT solicits comments
from the public to better inform its rulemaking process. DOT posts
these comments, without edit, including any personal information the
commenter provides, to www.regulations.gov, as described in the system
of records notice (DOT/ALL-14 FDMS), which can be reviewed at
www.dot.gov/privacy.
    Public Participation: The Federal eRulemaking Portal is available
24 hours each day, 365 days each year. You can obtain electronic
submission and retrieval help and guidelines under the ``FAQ'' section
of the Federal eRulemaking Portal website. If you want us to notify you
that we received your comments, please include a self-addressed,
stamped envelope or postcard, or print the acknowledgement page that
appears after submitting comments online. Comments received after the
comment closing date will be included in the docket and will be
considered to the extent practicable.

FOR FURTHER INFORMATION CONTACT: Bryan Price, Chief, Drug and Alcohol
Programs Division, FMCSA, DOT, West Building 6th Floor, 1200 New Jersey
Avenue SE, Washington, DC 20590. Telephone:<PHONE_NUMBER>; email:
[email protected].

SUPPLEMENTARY INFORMATION:

Background

    Agency regulations at 49 CFR part 382 apply to persons and
employers of such persons who operate CMVs in commerce in the United
States and who are subject to the CDL requirements in 49 CFR part 383
or the equivalent CDL requirements for Canadian and Mexican drivers (49
CFR 382.103(a)). Part 382 requires that employers conduct pre-
employment drug testing, post-accident testing, random drug and alcohol
testing, and reasonable suspicion testing, as well as RTD testing and
follow-up testing for those drivers who test positive or otherwise
violate DOT drug and alcohol program requirements. Motor carrier
employers are prohibited from allowing an employee to perform safety-
sensitive functions, which include operating a CMV, if the employee
tests positive on a DOT drug or alcohol test, refuses to take a
required test, or otherwise violates the DOT or FMCSA drug and alcohol
testing regulations.
    Section 32402 of the Moving Ahead for Progress in the 21st Century
Act (MAP-21) requires that the Secretary of Transportation establish,
operate, and maintain a national clearinghouse for records relating to
alcohol and controlled substances testing of CMV operators to improve
compliance with the DOT's alcohol and controlled substances testing
program and to enhance the safety of our roadways by reducing crashes
and injuries involving the misuse of alcohol or use of controlled
substances by operators of CMVs. As noted above, FMCSA published a
final rule on December 5, 2016, with an effective date of January 4,
2017, and a compliance date of January 6, 2020, to implement the
requirements of the Clearinghouse. The FMCSA first began collecting
data in September 2019 relating to authorized users' registration in
the Clearinghouse. On January 6, 2020, FMCSA began collecting data
related to drivers' drug and alcohol program violations and associated
return to duty process as well and queries conducted by employers on
CDL or CLP holders.
    The Clearinghouse functions as a repository for records relating to
the positive test results and test refusals of CMV operators and
violations by such operators of prohibitions set forth in Part 382,
Subpart B, of title 49, Code of Federal Regulations. An employer
utilizes the Clearinghouse to determine whether current and prospective
employees have incurred a drug or alcohol program violation that would
prohibit them from performing safety-sensitive functions, including
operating a CMV.
    The Clearinghouse provides FMCSA and employers the necessary tools
to identify drivers who are prohibited from operating a CMV and ensure
that such drivers receive the required evaluation and treatment before
resuming safety-sensitive functions. Specifically, information
maintained in the Clearinghouse will ensure that drivers who commit a
drug or alcohol program violation while working for one employer and
attempt to find work with another employer, can no longer conceal their
drug and alcohol violations merely by moving on to the next job or the
next state. Drug and alcohol violation records maintained in the
Clearinghouse will follow the driver regardless of how many times he or
she changes employers, seeks employment, or applies for a CDL in a
different State.
    The information in the Clearinghouse is used by FMCSA and its State
partners for enforcement purposes:
     Ensure employers are meeting their pre-employment
investigation and reporting requirements.

     Place drivers out of service if drivers are found to be
operating a CMV without completing the RTD process.
     Ensure medical review officers (MROs) and substance abuse
professionals (SAPs) meet their reporting requirements.
    Only authorized users, including employers and their service
agents, and Federal and State enforcement personnel and State Driver
Licensing Agencies (SDLAs) may register and access the Clearinghouse
for designated purposes. State enforcement personnel may also receive
the driver's eligibility status to operate a CMV, based on
Clearinghouse information, when they check Query Central, the
Commercial Driver's License Information System, or The National Law
Enforcement Telecommunications System (NLets) for driver information.
The FMCSA will share a driver's drug and alcohol violation information
with the National Transportation Safety Board when it is investigating
a crash involving that driver.
    Drivers may access their own information, but not information of
other drivers. The Clearinghouse meets all relevant federal security
standards and FMCSA continuously monitors compliance with applicable
security regulations.
    Title: Commercial Driver's License Drug and Alcohol Clearinghouse.
    OMB Control Number: 2126-0057.
    Type of Request: Renewal of a currently approved information
collection.
    Respondents: Motor carriers (employers), drivers, MROs, SAPs,
consortia/third-party administrators (C/TPAs), and SDLAs.
    Estimated Number of Respondents: 10,289,839.
    Estimated Time per Response: Varies; 10 to 20 minutes.
    Expiration Date: February 28, 2023.
    Frequency of Response: On occasion.
    A user's role will determine the frequency of the response in the
Clearinghouse.
     Employers, or C/TPAs acting on behalf of an employer: at a
minimum, employers are required to query the Clearinghouse for each
driver they currently employ at least once a year. Employers must query
the Clearinghouse for all prospective employees, as needed. In
addition, employers report to the Clearinghouse alcohol confirmation
tests with a concentration of 0.04 or higher, refusal to test
(alcohol), refusal to test (drug) that is not determined by an MRO, and
actual knowledge of violations, negative RTD testing, and completion of
the follow-up testing plan. Employer reporting must be completed by the
close of the third business day following the date they obtained the
information on a driver.
     MROs: verified positive, adulterated or substituted drug
test result and refusals to tests (drug) must be entered to the
Clearinghouse on occasion, but no later than two business days after
making a determination or verification.
     SAPs: must enter the initial assessment date and the date
the driver successfully complied with RTD requirements. SAPs are
required to enter this information on occasion by the close of business
day following the date of the initial assessment or completion of the
RTD process.
     SDLAs may query the Clearinghouse prior to specified
licensing transactions to determine if there are existing drug or
alcohol program violations.
     Drivers must provide their specific consent to pre-
employment queries electronically through the Clearinghouse.
    Estimated Total Annual Burden: 1,761,149.
    Estimated Total Number Respondents: 10,289,839.
    Public Comments Invited: You are asked to comment on any aspect of
this information collection, including: (1) whether the proposed
collection is necessary for the performance of FMCSA's functions; (2)
the accuracy of the estimated burden; (3) ways for FMCSA to enhance the
quality, usefulness, and clarity of the collected information; and (4)
ways that the burden could be minimized without reducing the quality of
the collected information. The agency will summarize or include your
comments in the request for OMB's clearance of this information
collection.

    Issued under the authority of 49 CFR 1.87 on:
Thomas P. Keane,
Associate Administrator, Office of Research and Registration.
[FR Doc. 2022-23981 Filed 11-3-22; 8:45 am]
BILLING CODE 4910-EX-P


	UNITED STATES ENVIRONMENTAL PROTECTION AGENCY

	WASHINGTON, D.C.  20460

	OFFICE OF PREVENTION,

	PESTICIDES AND TOXIC

		SUBSTANCES

	April 23, 2007

	DP Barcode: D339258										PC Code: 036602

MEMORANDUM

SUBJECT:	Drinking water assessment for mandipropamid and its two
degradates (SYN500003, SYN504851) use on brassica vegetables, bulb
vegetables, cucurbits, fruiting vegetables, grapes, leafy vegetables,
potatoes, tomatoes, tuberous and corm vegetables.

TO:		Dennis McNeilly, Chemist

		Registration Action Branch 2

		Health Effects Division (P7509)

FROM:	Ibrahim Abdel-Saheb, Ph.D., Environmental Scientist

Environmental Risk Branch II

Environmental Fate and Effects Division

THRU:	Dana Spatz, Senior Chemist

Environmental Risk Branch II

Environmental Fate and Effects Division

Tom Bailey, Ph.D., Branch Chief

Environmental Risk Branch II

Environmental Fate and Effects Division

INTRODUCTION

	This memorandum transmits the Tier I Estimated Environmental
Concentrations (EECs) resulting from 4 applications of 0.13 lb ai/acre
of mandipropamid and its two degradates (SYN500003 and SYN504851). HED
requested to include these two degradates in this water assessment due
to their high amounts formed in laboratory studies (9.4 and 38% of the
applied radioactivity under aerobic aquatic conditions), and
toxicological concerns.

CONCLUSIONS

	A screening assessment of estimated environmental concentrations (EECs)
for mandipropamid and its major aquatic degradates (SYN500003 and
SYN504851) in drinking water was conducted.  Screening models were used
to determine estimated concentrations in ground water and surface water.
 A national PCA of 0.87 (default) was used in order to better reflect
the expected exposures from the proposed uses.

	Based on surface (FIRST 1.1.0) and ground water (SCI-GROW 2.3) modeling
, the surface and groundwater Expected Environmental Concentrations
(EEC) of mandipropamid  and its major degradates (SYN500003 and
SYN504851) are shown in table 1.

Table 1. Estimated drinking water concentrations to be used for exposure
to mandipropamid and its major degradates (SYN500003, SYN504851) in
drinking water derived from surface water and ground water.

	Model EEC Value (μg/L)

	Mandipropamid	SYN500003	SYN504851	Four applications @0.13 lbai/A with 7
days interval between applications	PCA %

Acute	25.2	2.323	8.993

0.87

Annual average (chronic)	1.00	0.381	5.858

0.87

Groundwater	5.22E-02	5.85E-01	1.73E	Four applications @0.13 lbai/A with
7 days interval between applications	None

BACKGROUND

Mandipropamid is a new pesticide (also known as Revus) is the active
ingredient in the fungicide

RevusTM, which is proposed for control of a certain diseases in brassica
vegetables, bulb vegetables,

cucurbits, fruiting vegetables, grapes, leafy vegetables, potatoes,
tomatoes, tuberous and corm

vegetables.

Groundwater and surface water monitoring data are not available to the
Environmental Fate and Effects Division (EFED) for mandipropamid or its
degradates (new chemical). Screening models were used to determine
drinking water EECs.

SURFACE WATER

Table 2. Selected Surface Water Exposure Inputs for FIRST 1.1.0 for
Mandipropamid.

MODEL INPUT VARIABLE	INPUT VALUE	COMMENTS

Application rate (lb ai/A)	0.13	EPA Reg. 100-RELU

Number of application	4	EPA Reg. 100-RELU

Interval between appl. (d)	7	EPA Reg. 100-RELU

Koc(mL/g)	405.1	MRID# 46800040-41; Lowest non-sand;  Input Parameters
Guidance, 2002

Aerobic Soil Metabolic Half-life (days)	81.3 (parent)	MRID#
46800020,21,22,24,25,27-28; Input Parameters Guidance, 2002

Wetted in?	No	EPA Reg. 100-RELU

Depth of Incorporation (cm)	0	EPA Reg. 100-RELU

Method of application	Aerial	EPA Reg. 100-RELU

Percent cropped area	0.87	PCA that gives the max. EECs used;  FIRST
users manual.

Solubility (mg/L)	2.3	MRID# 46800007, 46800008

Aerobic Aquatic Metabolic Half-life (days)	19.3	MRID# 46800033-34;
Input Parameters Guidance, 2002

Hydrolysis (pH 7) half-life (days)	0	MRID# 46800007, 46800008

Aqt. Photolysis Half-life (days)	1.1	MRID# 46800014; maximum value.

Table 3. Selected Surface Water Exposure Inputs for FIRST 1.1.0 for
mandipropamid degradate, SYN 00003.

MODEL INPUT VARIABLE	INPUT VALUE	Data Source/ Comments

Application rate (lb ai/A)	0.007*	EPA Reg. 100-RELU

Number of application	4	EPA Reg. 100-RELU

Interval between appl. (d) 	7	EPA Reg. 100-RELU

Koc(mL/g)	2.89	MRID# 46800037; Lowest non-sand;  Input Parameters
Guidance, 2002

Aerobic Soil Metabolic Half-life (days)	81.3 (parent)	No data available
for degradate; MRID# 46800020,21,22,24,25,27-28; Input Parameters
Guidance, 2002

Wetted in?	No	EPA Reg. 100-RELU

Depth of Incorporation (cm)	0	EPA Reg. 100-RELU

Method of application	Ground	EPA Reg. 100-RELU

Percent cropped area	0.87	PCA that gives the max. EECs used;  FIRST
users manual.

Solubility (mg/L)	170000	Europena Federal Office for Food Safety;
Monograph prepared in the context of inclusion of following active
substance in Annex I of the Council Directive 91/414/EEC
(Mandipropamid), 2006.

Aerobic Aquatic Metabolic Half-life (days)	58.1	MRID# 46800029;  Input
Parameters Guidance, 2002

Hydrolysis (pH 7) half-life (days)	0 	No data available for
degradate;MRID# 46800007, 46800008

Aqt. Photolysis Half-life (days)	0	No data available for degradate;
Input Parameters Guidance, 2002

	*: Application rate was calculated by multiplying the parent appl.
rate X maximum percent of degradate formed (i.e. 	9.4% of applied
radioactivity; MRID# 46800031) X (degradate M.Wt/parent M.Wt).

Table4. Selected Surface Water Exposure Inputs for FIRST 1.1.0 for
mandipropamid degradate, SYN 504851.

MODEL INPUT VARIABLE	INPUT VALUE	Data Source/ Comments

Application rate (lb ai/A)	0.027*	EPA Reg. 100-RELU

Number of application	4	EPA Reg. 100-RELU

Interval between appl. (d)	7	EPA Reg. 100-RELU

Koc(mL/g)	3	MRID# 46800044; Lowest non-sand;  Input Parameters Guidance,
2002

Aerobic Soil Metabolic Half-life (days)	81.3 (parent)	No data available
for degradate; MRID# 46800020,21,22,24,25,27-28; Input Parameters
Guidance, 2002

Wetted in?	No	EPA Reg. 100-RELU

Depth of Incorporation (cm)	0	EPA Reg. 100-RELU

Method of application	Ground	EPA Reg. 100-RELU

Percent cropped area	0.87	PCA that gives the max. EECs used;  FIRST
users manual.

Solubility (mg/L)	500000	Europena Federal Office for Food Safety;
Monograph prepared in the context of inclusion of following active
substance in Annex I of the Council Directive 91/414/EEC
(Mandipropamid), 2006.

Aerobic Aquatic Metabolic

Half-life (days)	1323 (441 X 3)	MRID# 46800029;  single half life
multiplied by 3; Input Parameters Guidance, 2002

Hydrolysis (pH 7) half-life (days)	0 	No data available for degradate;
MRID# 46800007, 46800008

Aqt. Photolysis Half-life (days)	0	No data available for degradate;
Input Parameters Guidance, 2002

	**: Application rate was calculated by multiplying the parent appl.
rate X maximum percent of degradate formed 	(i.e. 38% of applied
radioactivity; MRID# 46800031) X (degradate M.Wt/parent M.Wt).

GROUND WATER

The SCI-GROW model is based on scaled ground water concentration from
ground water monitoring studies, environmental fate properties (aerobic
soil half-lives and organic carbon partitioning coefficients-Koc 's) and
application rates. The model is based on permeable soils that are
vulnerable to leaching and on shallow ground water (10-30 feet).
SCI-GROW version 2.3 (executable file dated 08/05/2003) was used to
estimate concentrations of mandipropamid and its major degradate
(SYN500003, SYN504851) that could be found in drinking water derived
from ground water, using the input values listed in the table 3.

Table 5. Ground Water Exposure Inputs for SCI-GROW for parent
mandipropamid and its two degradate  (SYN 00003, SYN 504851).

MODEL INPUT VARIABLE	INPUT VALUE	Data Source/ Comments

	Parent	SYN 00003	SYN 504851

	Application Rate (lbs. ai/A)	0.13	0.007*	0.027*	EPA Reg. 100-RELU

Maximum No. of Applications	4	4	4	EPA Reg. 100-RELU

Koc	782	2.92	5	Median non-sand. MRID 46800038-41 (parent); 46800037 (SYN
00003), 46800044 (SYN 504851);  Input parameter guidance, 2002.

Aerobic Soil Metabolic Half-life(days)	75.1 (median)	81.3 (parent)	81.3
(parent)	No data available for degradate; MRID# 46800033-34; MRID#
46800029; Input parameter guidance, 2002.

*: Application rate was calculated by multiplying the parent appl. rates
X maximum percent of degradate formed X (degradate M.Wt/parent M.Wt).

Results from the SCI-GROW screening model predict that the maximum
chronic and acute concentration of parent mandipropamid and its major
degradate (SYN500003, SYN504851) in shallow ground water is not expected
to exceed 4.19E+01 µg/L for the current maximum seasonal use rate.

APPENDIX I

FIRST MODEL 1.1.0 INPUT & OUTPUT FILES

RUN No.   1 FOR Mandipropamid    ON   all           * INPUT VALUES *

------------------------------------------------------------------------
--------------------------------

    RATE (#/AC)   No.APPS &   SOIL  SOLUBIL  APPL TYPE  %CROPPED INCORP

     ONE(MULT)    INTERVAL    Koc   (PPM )   (%DRIFT)     AREA    (IN)

------------------------------------------------------------------------
--------------------------------

   .130(   .477)         4       7           405.1    2.3
AERIAL(16.0)  87.0    .0

   FIELD AND RESERVOIR HALFLIFE VALUES (DAYS)

------------------------------------------------------------------------
-----------------------------------------

   METABOLIC  DAYS UNTIL  HYDROLYSIS   PHOTOLYSIS   METABOLIC  COMBINED

    (FIELD)  RAIN/RUNOFF  (RESERVOIR)  (RES.-EFF)   (RESER.)   (RESER.)

------------------------------------------------------------------------
-------------------------------------------

     81.30        2          N/A      1.10-  136.40    19.30     16.91

   UNTREATED WATER CONC (MICROGRAMS/LITER (PPB)) Ver 1.1.0 DEC 12, 2005

------------------------------------------------------------------------
----------

        PEAK DAY  (ACUTE)      ANNUAL AVERAGE (CHRONIC)

          CONCENTRATION             CONCENTRATION

------------------------------------------------------------------------
----------

1.006

RUN No.   2 FOR  SYN00003         ON   all           * INPUT VALUES *

   --------------------------------------------------------------------

    RATE (#/AC)   No.APPS &   SOIL  SOLUBIL  APPL TYPE  %CROPPED INCORP

     ONE(MULT)    INTERVAL    Koc   (PPM )   (%DRIFT)     AREA    (IN)

   --------------------------------------------------------------------

   .007(   .026)   4   7       2.9*******   GROUND( 6.4)  87.0    .0

   FIELD AND RESERVOIR HALFLIFE VALUES (DAYS)

   --------------------------------------------------------------------

   METABOLIC  DAYS UNTIL  HYDROLYSIS   PHOTOLYSIS   METABOLIC  COMBINED

    (FIELD)  RAIN/RUNOFF  (RESERVOIR)  (RES.-EFF)   (RESER.)   (RESER.)

   --------------------------------------------------------------------

     81.30        2          N/A       .00-     .00    58.10     58.10

   UNTREATED WATER CONC (MICROGRAMS/LITER (PPB)) Ver 1.1.0 DEC 12, 2005

   --------------------------------------------------------------------

        PEAK DAY  (ACUTE)      ANNUAL AVERAGE (CHRONIC)

          CONCENTRATION             CONCENTRATION

   --------------------------------------------------------------------

              2.323                     		  .381

   RUN No.   3 FOR SYN504851        ON   all           * INPUT VALUES *

   --------------------------------------------------------------------

    RATE (#/AC)   No.APPS &   SOIL  SOLUBIL  APPL TYPE  %CROPPED INCORP

     ONE(MULT)    INTERVAL    Koc   (PPM )   (%DRIFT)     AREA    (IN)

   --------------------------------------------------------------------

   .027(   .099)   4   7       3.050000.0   GROUND( 6.4)  87.0    .0

   FIELD AND RESERVOIR HALFLIFE VALUES (DAYS)

   --------------------------------------------------------------------

   METABOLIC  DAYS UNTIL  HYDROLYSIS   PHOTOLYSIS   METABOLIC  COMBINED

    (FIELD)  RAIN/RUNOFF  (RESERVOIR)  (RES.-EFF)   (RESER.)   (RESER.)

   --------------------------------------------------------------------

     81.30        2          N/A       .00-     .00   ******   1323.00

   UNTREATED WATER CONC (MICROGRAMS/LITER (PPB)) Ver 1.1.0 DEC 12, 2005

   --------------------------------------------------------------------

        PEAK DAY  (ACUTE)      ANNUAL AVERAGE (CHRONIC)

          CONCENTRATION             CONCENTRATION

   --------------------------------------------------------------------

              8.993           		           5.858

SCI-GROW MODEL 2.3 INPUT & OUTPUT FILES

SCIGROW

VERSION 2.3

ENVIRONMENTAL FATE AND EFFECTS DIVISION

OFFICE OF PESTICIDE PROGRAMS

U.S. ENVIRONMENTAL PROTECTION AGENCY

SCREENING MODEL

FOR AQUATIC PESTICIDE EXPOSURE

 SciGrow version 2.3

 chemical:Manidpropamid

 time is  4/19/2007  16:20: 6

 -----------------------------------------------------------------------
-

  Application      Number of       Total Use    Koc      Soil Aerobic

  rate (lb/acre)  applications   (lb/acre/yr)  (ml/g)   metabolism
(days)

 -----------------------------------------------------------------------
-

      0.130           4.0           0.520      7.82E+02       75.1

 -----------------------------------------------------------------------
-

 groundwater screening cond (ppb) =   5.22E-02

 ***********************************************************************
*

		SCIGROW

                          VERSION 2.3

            ENVIRONMENTAL FATE AND EFFECTS DIVISION

                 OFFICE OF PESTICIDE PROGRAMS

             U.S. ENVIRONMENTAL PROTECTION AGENCY

                        SCREENING MODEL

                FOR AQUATIC PESTICIDE EXPOSURE

 SciGrow version 2.3

 chemical:SYN00003

 time is  4/23/2007  15:55:32

 -----------------------------------------------------------------------
-

  Application      Number of       Total Use    Koc      Soil Aerobic

  rate (lb/acre)  applications   (lb/acre/yr)  (ml/g)   metabolism
(days)

 -----------------------------------------------------------------------
-

      0.007           4.0           0.028      2.92E+00       81.3

 -----------------------------------------------------------------------
-

 groundwater screening cond (ppb) =   5.85E-01

 ***********************************************************************
*

                           SCIGROW

                          VERSION 2.3

            ENVIRONMENTAL FATE AND EFFECTS DIVISION

                 OFFICE OF PESTICIDE PROGRAMS

             U.S. ENVIRONMENTAL PROTECTION AGENCY

                        SCREENING MODEL

                FOR AQUATIC PESTICIDE EXPOSURE

 SciGrow version 2.3

 chemical:SYN504851

 time is  4/23/2007  15:56: 6

 -----------------------------------------------------------------------
-

  Application      Number of       Total Use    Koc      Soil Aerobic

  rate (lb/acre)  applications   (lb/acre/yr)  (ml/g)   metabolism
(days)

 -----------------------------------------------------------------------
-

      0.027           4.0           0.108      5.00E+00       81.3

 -----------------------------------------------------------------------
-

 groundwater screening cond (ppb) =   1.73E+00

 ***********************************************************************
*

 PAGE

 PAGE  2


[Federal Register Volume 87, Number 102 (Thursday, May 26, 2022)]
[Notices]
[Page 32068]
[FR Doc No: 2022-11372]

-----------------------------------------------------------------------

DEPARTMENT OF TRANSPORTATION

Federal Railroad Administration

[Docket Number FRA-2016-0108]

Petition for Extension of Waiver of Compliance

    Under part 211 of title 49 Code of Federal Regulations (CFR), this
document provides the public notice that on April 29, 2022, Union
Pacific Railroad (UPRR) petitioned the Federal Railroad Administration
(FRA) to extend a waiver of compliance from certain provisions of the
Federal railroad safety regulations contained at 49 CFR 236.566,
Locomotive of each train operating in train stop, train control, or cab
signal territory: Equipped. The relevant FRA Docket Number is FRA-2016-
0108.
    Specifically, UPRR requests a temporary extension of relief from
Sec.  236.566 to allow it to comply with a condition of FRA's decision
letter dated April 6, 2022, primarily concerning Docket Number FRA-
2021-0011.\1\ The condition concerns slide detector fences, where
existent, being fully integrated with positive train control (PTC) via
wayside signal systems. UPRR states that four of its subdivision line
segments (Portland, Evanston, Rawlins, and Laramie) require additional
interconnections with PTC to be fully compliant with the condition in
the April 6, 2022, letter. UPRR requests an extension of the relief in
Docket Number FRA-2016-0108 for 12 months to complete the work, which
consists of modifications to signaling appliances and the construction
of communications infrastructure in some cases. Additionally, UPRR
requests modification of two conditions of the June 9, 2020, decision
letter in Docket Number FRA-2016-0108 \2\ to allow UPRR to immediately
begin to decommission its locomotives' onboard automatic train control
and automatic cab signal systems.
---------------------------------------------------------------------------

    \1\ See https://www.regulations.gov/document/FRA-2016-0108-0018.
    \2\ https://www.regulations.gov/document/FRA-2016-0108-0017.
_____________________________________-

    A copy of the petition, as well as any written communications
concerning the petition, is available for review online at
www.regulations.gov.
    Interested parties are invited to participate in these proceedings
by submitting written views, data, or comments. FRA does not anticipate
scheduling a public hearing in connection with these proceedings since
the facts do not appear to warrant a hearing. If any interested party
desires an opportunity for oral comment and a public hearing, they
should notify FRA, in writing, before the end of the comment period and
specify the basis for their request.
    All communications concerning these proceedings should identify the
appropriate docket number and may be submitted at http://www.regulations.gov. Follow the online instructions for submitting
comments.
    Communications received by July 25, 2022 will be considered by FRA
before final action is taken. Comments received after that date will be
considered if practicable.
    Anyone can search the electronic form of any written communications
and comments received into any of our dockets by the name of the
individual submitting the comment (or signing the document, if
submitted on behalf of an association, business, labor union, etc.).
Under 5 U.S.C. 553(c), the U.S. Department of Transportation (DOT)
solicits comments from the public to better inform its processes. DOT
posts these comments, without edit, including any personal information
the commenter provides, to www.regulations.gov, as described in the
system of records notice (DOT/ALL-14 FDMS), which can be reviewed at
https://www.transportation.gov/privacy. See also https://www.regulations.gov/privacy-notice for the privacy notice of
regulations.gov.

    Issued in Washington, DC.
John Karl Alexy,
Associate Administrator for Railroad Safety, Chief Safety Officer.
[FR Doc. 2022-11372 Filed 5-25-22; 8:45 am]
BILLING CODE 4910-06-P